Links

Home

FDA Information

Aloxi

This page contains recent news articles, when available, and an overview of Aloxi (palonosetron)Recent news articles mentioning Aloxi

HELSINN HEALTHCARE SA Announces Patent Extension for Aloxi(R ...  -  Feb 15, 2007
Drug Newswire (press release), Aloxi(R) is approved by the US Food and Drug Administration (FDA) for the prevention of acute nausea and vomiting associated with initial and repeat courses

MGI Pharma Holds Off on Aloxi Outlook  -  Feb 7, 2007
Forbes, Cancer drug developer MGI Pharma Inc. said Wednesday it won't provide 2007 sales guidance for its Aloxi medication due to changes in the

MGI Pharma receives patent extension on nausea drug  -  Feb 13, 2007
Pharmaceutical Business Review MGI Pharma and its partner Helsinn Healthcare have said that a patent term extension has been granted covering Aloxi injection in the US.

MGI PHARMA Reports Fourth Quarter and Full Year 2006 Financial Results  -  Feb 8, 2007
PharmaLive.com (press release), ..."We announced positive phase 3 results for Aloxi in post operative nausea and vomiting and for the first of two pivotal trials of Aquavan.

Correction: MGI Pharma Earnings Story  -  Feb 8, 2007
Forbes, 7 story about MGI Pharma Inc.'s fourth-quarter results, The Associated Press reported erroneously that a generic version of its Aloxi drug,

Earnings, outlook lift MGI stock  -  Feb 9, 2007
Pioneer Press, Analysts have feared that sales of the company's drug Aloxi, which generated more than half of MGI Pharma's revenue in 2006, would be hurt by the

Company roundup  -  Feb 13, 2007
Minneapolis Star Tribune (subscription), Aloxi is approved by the Food and Drug Administration for prevention of nausea and vomiting associated with cancer chemotherapy. Navarre Corp., New Hope,

MGI Pharma anti-nausea drug gets patent extension  -  Feb 13, 2007
Reuters O: Quote, Profile , Research) and Swiss drug company Helsinn Healthcare SA on Tuesday said the anti-nausea drug Aloxi received a five-year US patent

Correction: MGI Pharma Outlook Story  -  Feb 8, 2007
Forbes, 7 story about MGI Pharma Inc.'s outlook, The Associated Press reported erroneously that a generic version of its anti-nausea treatment Aloxi became

MGI Pharma Narrows 4th-Quarter Loss  -  Feb 7, 2007
Forbes, Cancer drug developer MGI Pharma Inc. reported a narrower fourth-quarter loss on Wednesday despite declining sales of its Aloxi anti-nausea drug.

UPDATE 1-MGI Pharma loss narrows, blood disorder drug helps  -  Feb 7, 2007
Reuters Quarterly US sales of Aloxi, MGI Pharma's biggest product which is used to prevent chemotherapy-related nausea and vomiting, fell to $49.6 million from $67

MGI Pharma narrows 4th-quarter loss  -  Feb 7, 2007
ABCmoney.co.uk, MINNEAPOLIS (AFX) - Cancer drug developer MGI Pharma Inc. reported a narrower fourth-quarter loss on Wednesday despite declining sales of its Aloxi

MGI Pharma loss narrows  -  Feb 7, 2007
Reuters Dacogen cancer drug offset declining revenue from nausea treatment Aloxi, which is now facing competition from a generic form of a similar medicine.

MGI Pharma to Present at the 2007 Merrill Lynch Global ...  -  Feb 1, 2007
PharmaLive.com (press release), MGI PHARMA markets Aloxi(R) (palonosetron hydrochloride) Injection, Dacogen(TM) (decitabine) for Injection and Gliadel(R) Wafer (polifeprosan 20 with

MGI PHARMA to Present at the 2007 Merrill Lynch Global ...  -  Jan 31, 2007
dBusinessNews Minneapolis (press release), MGI PHARMA markets Aloxi® (palonosetron hydrochloride) Injection, Dacogen™ (decitabine) for Injection and Gliadel® Wafer (polifeprosan 20 with carmustine

Biotech Day In Review: Another Setback for Acomplia from Sanofi ...  -  Feb 14, 2007
Seeking Alpha, MGI Pharma (MOGN) and Helsinn Healthcare SA of Switzerland received a five-year extension of their patent for Aloxi, a treatment for nausea and vomiting

(PRN) - Crdentia Completes Private Placements of Common Stock ...  -  Feb 13, 2007
Bolsamania.com, ...(PRN) - HELSINN HEALTHCARE SA Announces Patent Extension for Aloxi(R) Injection in the US ... [+]. (PRN) - Rawlings to Unveil Ballot of Top 50 All-Time

Other uses for Aloxi [MedMaster Patient Drug Information database]

Before using darbepoetin alfa,

  • tell your doctor and pharmacist if you are allergic to darbepoetin alfa, epoetin alfa (Epogen, Procrit), medications made from animal cells, albumin, any other medications, or polysorbate 80. Ask your doctor or pharmacist if you don't know if a medication you are allergic to is made from animal cells.
  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking. Be sure to mention any of the following: estrogen-containing products such as hormone replacement therapy or hormonal contraceptives (birth control pills, patches, rings, injections, or implants); iron supplements; or medications to control high blood pressure. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
  • tell your doctor if you have or have ever had bleeding problems or diseases that affect your blood such as sickle cell disease (an inherited blood disease that causes pain, anemia, and organ damage), thalassemia (an inherited blood disease that causes abnormal development and other problems), or porphyria (an inherited blood disease that may cause skin or nervous system problems); blood clots in your heart, legs, or lungs; a heart attack; parathyroid disease (problems with the small glands in the neck that help balance calcium levels in the body), especially if it has affected your bones; seizures; stroke or mini-stroke (TIA); tumors; heart disease, or any disease that affects your brain or nervous system.
  • tell your doctor if you have used darbepoetin alfa or another erythropoietic protein such as epoetin alfa (Epogen, Procrit) in the past. Be sure to tell your doctor if your anemia worsened during your treatment with one of these medications, or if you were ever told to stop using one of these medications.
  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while using darbepoetin alfa, call your doctor.
  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are using darbepoetin alfa.
  • you should know that your blood pressure may rise while you are using darbepoetin alfa. Tell your doctor if you have or have ever had high blood pressure. Be sure to check your blood pressure as often as your doctor tells you that you should, to call your doctor if your blood pressure is higher than your doctor says it should be, and to take any medications your doctor prescribes to control your blood pressure exactly as directed.
  • You should call your doctor if you are planning to travel or if your activity becomes limited, such as spending more time sitting or in bed.
  • if you are on hemodialysis, you should know that blood clots may form in the tubing that goes into your vein. Call your doctor if you think there is a clot in your tubing.




medivore.com